Correlation Between Scpharmaceuticals and Cingulate Warrants

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Cingulate Warrants, you can compare the effects of market volatilities on Scpharmaceuticals and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Cingulate Warrants.

Diversification Opportunities for Scpharmaceuticals and Cingulate Warrants

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Scpharmaceuticals and Cingulate is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Cingulate Warrants go up and down completely randomly.

Pair Corralation between Scpharmaceuticals and Cingulate Warrants

Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Cingulate Warrants. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 4.34 times less risky than Cingulate Warrants. The stock trades about -0.13 of its potential returns per unit of risk. The Cingulate Warrants is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  5.22  in Cingulate Warrants on August 30, 2024 and sell it today you would lose (1.72) from holding Cingulate Warrants or give up 32.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Scpharmaceuticals  vs.  Cingulate Warrants

 Performance 
       Timeline  
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Cingulate Warrants 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Scpharmaceuticals and Cingulate Warrants Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scpharmaceuticals and Cingulate Warrants

The main advantage of trading using opposite Scpharmaceuticals and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.
The idea behind Scpharmaceuticals and Cingulate Warrants pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bonds Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume